Search Results Search Sort by RelevanceMost Recent Medicine and Society Oct 2010 The Personal, Social, and Economic Determinants of Cardiovascular Disease Jane S. Jue, MD, MSc Personal, social, economic, and environmental factors all contribute to the increased incidence of cardiovascular disease in the United States. Virtual Mentor. 2010;12(10):812-817. doi: 10.1001/virtualmentor.2010.12.10.msoc1-1010. Health Law Jul 2009 Court Support for FDA Regulation of Drug Importation Kristin E. Schleiter, JD, LLM U.S. regulations prohibit the importation of drugs from foreign countries by individuals and groups other than the manufacturer of the drugs. Virtual Mentor. 2009;11(7):521-526. doi: 10.1001/virtualmentor.2009.11.7.hlaw1-0907. Medicine and Society Nov 2009 Medical Education Meets Health Care Reform Jordan J. Cohen, MD There are four key elements of health system reform that medical educators must endeavor to implement. Virtual Mentor. 2009;11(11):896-899. doi: 10.1001/virtualmentor.2009.11.11.msoc1-0911. AMA Code Says Sep 2004 Physician-Scientists and Social Responsibility Shane K. Green, PhD A new AMA policy provide guidance for physician-scientists on dual-use research issues and reinforces the message that ethical conduct in scientific research ultimately rests with the individual researcher. Virtual Mentor. 2004;6(9):416-419. doi: 10.1001/virtualmentor.2004.6.9.code1-0409. Case and Commentary Aug 2004 Is Chronic Pain Treatment the Neurologist's Job? Erich Garland, MD Patients who are seeking pain management with opioids can be difficult for neurologists to manage. Virtual Mentor. 2004;6(8):345-346. doi: 10.1001/virtualmentor.2004.6.8.ccas3-0408. State of the Art and Science Jan 2003 How to Change Routes of Administration of Opioids Audiey Kao, MD, PhD A formula designed to help physicians select appropriate dosage when changing the route of opioid administration for pain management. Virtual Mentor. 2003;5(1):19-20. doi: 10.1001/virtualmentor.2003.5.1.cprl1-0301. Case and Commentary Nov 2004 Who Is That? Expanding the Clinical Encounter Vijaya Arekapudi, MD Patients need to completely understand the role of any non-medical personnel present during a procedure and have the right to refuse their attendance. Virtual Mentor. 2004;6(11):486-487. doi: 10.1001/virtualmentor.2004.6.11.ccas3-0411. Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551. Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512. Viewpoint Jul 2024 Opioid Epidemic Grief and Characterological Harm Reduction Christy A. Rentmeester, PhD Becoming callous, bitter, or resentful are harms we can suffer when grieving losses, especially at epidemic scale. AMA J Ethics. 2024;26(7):E587-590. doi: 10.1001/amajethics.2024.587. Pagination First page « First Previous page ‹ Previous … Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Current page 19 Page 20 Page 21 Next page Next › Last page Last »
Medicine and Society Oct 2010 The Personal, Social, and Economic Determinants of Cardiovascular Disease Jane S. Jue, MD, MSc Personal, social, economic, and environmental factors all contribute to the increased incidence of cardiovascular disease in the United States. Virtual Mentor. 2010;12(10):812-817. doi: 10.1001/virtualmentor.2010.12.10.msoc1-1010.
Health Law Jul 2009 Court Support for FDA Regulation of Drug Importation Kristin E. Schleiter, JD, LLM U.S. regulations prohibit the importation of drugs from foreign countries by individuals and groups other than the manufacturer of the drugs. Virtual Mentor. 2009;11(7):521-526. doi: 10.1001/virtualmentor.2009.11.7.hlaw1-0907.
Medicine and Society Nov 2009 Medical Education Meets Health Care Reform Jordan J. Cohen, MD There are four key elements of health system reform that medical educators must endeavor to implement. Virtual Mentor. 2009;11(11):896-899. doi: 10.1001/virtualmentor.2009.11.11.msoc1-0911.
AMA Code Says Sep 2004 Physician-Scientists and Social Responsibility Shane K. Green, PhD A new AMA policy provide guidance for physician-scientists on dual-use research issues and reinforces the message that ethical conduct in scientific research ultimately rests with the individual researcher. Virtual Mentor. 2004;6(9):416-419. doi: 10.1001/virtualmentor.2004.6.9.code1-0409.
Case and Commentary Aug 2004 Is Chronic Pain Treatment the Neurologist's Job? Erich Garland, MD Patients who are seeking pain management with opioids can be difficult for neurologists to manage. Virtual Mentor. 2004;6(8):345-346. doi: 10.1001/virtualmentor.2004.6.8.ccas3-0408.
State of the Art and Science Jan 2003 How to Change Routes of Administration of Opioids Audiey Kao, MD, PhD A formula designed to help physicians select appropriate dosage when changing the route of opioid administration for pain management. Virtual Mentor. 2003;5(1):19-20. doi: 10.1001/virtualmentor.2003.5.1.cprl1-0301.
Case and Commentary Nov 2004 Who Is That? Expanding the Clinical Encounter Vijaya Arekapudi, MD Patients need to completely understand the role of any non-medical personnel present during a procedure and have the right to refuse their attendance. Virtual Mentor. 2004;6(11):486-487. doi: 10.1001/virtualmentor.2004.6.11.ccas3-0411.
Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551.
Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512.
Viewpoint Jul 2024 Opioid Epidemic Grief and Characterological Harm Reduction Christy A. Rentmeester, PhD Becoming callous, bitter, or resentful are harms we can suffer when grieving losses, especially at epidemic scale. AMA J Ethics. 2024;26(7):E587-590. doi: 10.1001/amajethics.2024.587.